Rezolute (RZLT) Amortization of Deferred Charges (2012 - 2020)
Rezolute (RZLT) reported Amortization of Deferred Charges of $80000.0 for Q4 2020, down 3.61% on a YoY basis from $83000.0 in Q1 2020, and up 35.59% sequentially from $59000.0 in Q3 2020.
Rezolute (RZLT) Amortization of Deferred Charges (2012 - 2020) Analysis & Trends
Rezolute (RZLT) has 6 years of Amortization of Deferred Charges data on file, last reported at $80000.0 in Q4 2020.
- For the quarter ending Q4 2020, Amortization of Deferred Charges fell 3.61% year-over-year to $80000.0; the trailing twelve-month figure through Dec 2020 stood at $3000.0 (down 99.51% YoY), and the FY2019 full-year result was $2.1 million, changed N/A from the prior year.
- Amortization of Deferred Charges rose to $80000.0 in Q4 2020, from $59000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $878000.0 in Q4 2018 to a low of -$136000.0 in Q1 2020.
- A 3-year average of $274000.0 and a median of $81500.0 in 2019 frame the typical range for Amortization of Deferred Charges.
- Peak annual rise in Amortization of Deferred Charges reached 11.32% in 2020, while the deepest fall reached 128.81% in 2020.
- Tracing RZLT's Amortization of Deferred Charges over 3 years: stood at $878000.0 in 2018, then slumped by 90.55% to $83000.0 in 2019, then retreated by 3.61% to $80000.0 in 2020.
- Business Quant data shows RZLT's Amortization of Deferred Charges at $80000.0 in Q4 2020, $59000.0 in Q3 2020, and -$136000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Rezolute | 517.94 Mn | 517.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 80,000.00 |
| Dec 31, 2020 | 80,000.00 |
| Sep 30, 2020 | 59,000.00 |
| Sep 30, 2020 | 59,000.00 |
| Mar 31, 2020 | -136,000.00 |
| Mar 31, 2020 | -136,000.00 |
| Dec 31, 2019 | 83,000.00 |
| Dec 31, 2019 | 83,000.00 |
| Sep 30, 2019 | 53,000.00 |
| Sep 30, 2019 | 53,000.00 |
| Mar 31, 2019 | 472,000.00 |
| Mar 31, 2019 | 472,000.00 |
| Dec 31, 2018 | 878,000.00 |
| Dec 31, 2018 | 878,000.00 |
| Sep 30, 2018 | 703,000.00 |
| Sep 30, 2018 | 703,000.00 |
| Mar 31, 2014 | 266,693.00 |
| Mar 31, 2014 | 266,693.00 |
| Dec 31, 2013 | 74,136.00 |
| Dec 31, 2013 | 74,136.00 |